Searchable abstracts of presentations at key conferences in endocrinology

ea0065p153 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Ipilimumab-induced hypophysitis with normal pituitary function: a series of 3 cases

Nogueira Edson , Morganstein Daniel

Introduction: Hypophysitis has been recognised as a frequent endocrine related side effect of immunotherapy with the CLTA-4 inhibitor Ipilimumab, with a prevalence of upto 17.4%. The most common symptoms of hypophysitis are headache and signs/symptoms of hypopituitarism. Whilst some patients have an enlarged pituitary on MRI, this is frequently normal. ACTH and TSH deficiencies are most common, but all anterior and posterior pituitary hormonal axis may be affected. Hypopituita...

ea0062p19 | Poster Presentations | EU2019

Two novel mutations in the Calcium Sensing Receptor (CASR) gene in patient s with biochemical investigations suggestive of Familial Hypocalciuric Hypercalcemia (FHH)

Samarasinghe Suhaniya , Nogueira Edson , Seechurn Shivshankar

Case history: Case 1: 18-year-old female referred with asymptomatic hypercalcaemia (adjusted calcium 2.69 mmol/l), phosphate 0.96 mmol/l, parathyroid hormone 2.6 pmol/l and total 25 hydroxyvitamin D 37 nmol/l. No evidence of end organ damage. Initial calcium: creatinine clearance ratio 0.0033 but the patient had a vitamin D 24 nmol/l. Case 2: A 53-year-old female referred with asymptomatic incidental hypercalcaemia (adjusted calcium 2.73–2.87 mmol/l), raised parathyroid h...

ea0050ep102 | Thyroid | SFEBES2017

Persisting biochemical thyrotoxicosis due to biotin supplementation in a patient with Graves’ disease

Nogueira Edson F , Abbara Ali , Tan Tricia , Comninos Alexander N

A 46-year-old lady was referred to endocrinology with thyrotoxicosis. She was diagnosed with Graves’ disease by her GP in October 2016 when presenting with classical symptoms and investigations [TSH<0.01 mIU/L (NR 0.3–4.2), fT4=34.3 pmol/L (NR 9–23), TSHrAb>30 u/mL (NR<0.4), and increased iodine uptake]. She was therefore started on carbimazole 15 mg/day. She returned to her GP in December 2016 reporting resolved symptoms, however, she ...

ea0050ep102 | Thyroid | SFEBES2017

Persisting biochemical thyrotoxicosis due to biotin supplementation in a patient with Graves’ disease

Nogueira Edson F , Abbara Ali , Tan Tricia , Comninos Alexander N

A 46-year-old lady was referred to endocrinology with thyrotoxicosis. She was diagnosed with Graves’ disease by her GP in October 2016 when presenting with classical symptoms and investigations [TSH<0.01 mIU/L (NR 0.3–4.2), fT4=34.3 pmol/L (NR 9–23), TSHrAb>30 u/mL (NR<0.4), and increased iodine uptake]. She was therefore started on carbimazole 15 mg/day. She returned to her GP in December 2016 reporting resolved symptoms, however, she ...

ea0062p49 | Poster Presentations | EU2019

A challenging case of transient hypercortisolism presenting with diabetic ketoacidosis: could this be cyclical Cushing’s syndrome?

Nogueira Edson , Samarasinghe Suhaniya , Qureshi Asjid , Seechurn Shivshankar

A 49-year-old female was admitted to with diabetic ketoacidosis (DKA) and newly diagnosed diabetes. Her only significant medical problem was malignant hypertension with poorly controlled blood pressure (BP) on four antihypertensive agents. She reported no exogenous glucocorticoid or liquorice ingestion. She also complained of a 6-month history of lethargy, weight gain, and a two-month history of easy bruising, lower-limb weakness, increasing polyuria and polydipsia. There was ...

ea0056p57 | Adrenal cortex (to include Cushing's) | ECE2018

A case of adrenal Cushing’s syndrome initially presenting with diabetic ketoacidosis

Nogueira Edson , Muralidhara Koteshwara , Rahman Mushtaqur , Darko Daniel , Seechurn Shivshankar

A 49-year-old female was admitted to medical HDU with diabetes ketoacidosis (DKA) and newly diagnosed diabetes. Six months previously she was diagnosed with malignant hypertension. She had poorly controlled blood pressure despite treatment with four anti-hypertensives, which were her only regular medication. She had never used any medications or creams containing glucocorticoids. She had no history of hypokalaemia and reported no use of liquorice. She recently attended an outp...

ea0021oc5.3 | Steroids and thyroid | SFEBES2009

Differential roles of PAPSS1 and PAPSS2 in the control of androgen synthesis

McNelis Joanne , Idkowiak Jan , Nogueira Edson , Ward Alexandra , Dhir Vivek , Arlt Wiebke

A key component of androgen synthesis is the availability of the pro-hormone DHEA, which is either converted to active androgens or inactivated to its sulfate ester DHEAS by DHEA sulfotransferase (SULT2A1). The latter reaction requires provision of the universal sulfate donor 3′-phosphoadenosine-5′-phosphosulfate, PAPS. In humans, PAPS is generated by the PAPS synthase isoforms PAPSS1 and PAPSS2. Recently, inactivating PAPSS2 mutations have been identified i...

ea0056p887 | Pituitary - Clinical | ECE2018

Investigation and initial management of hyponatraemia

Kostoula Melina , Bravis Vassiliki , Ramli Rozana , Nogueira Edson , Dua Radhika , Daunt Anna

Hyponatraemia is the commonest electrolyte disturbance in clinical practice and accounts for 15–20% of emergency admissions to hospital. It is thought that up to 30% of hospitalized patients develop a degree of hyponatraemia at some point during their admission. It is therefore an important problem. Management of inpatients with hyponatraemia remains problematic and an audit of our practice at St Mary’s Hospital, Imperial College Healthcare NHS Trust, has confirmed t...

ea0056p1099 | Thyroid (non-cancer) | ECE2018

A case of respiratory arrest associated with sepsis induced myxoedema coma

Nogueira Edson , Khin Kyaw , Hope David , Idowu Oluwagbemiga , Sathianathan Vivian , Darko Daniel , Rahman Mushtaqur

A 58-year old previously independent man with background of poorly-controlled hypothyroidism, T2DM, hypertension, ischaemic cardiomyopathy, and CKD presented to hospital feeling generally unwell, with a dry cough. His regular medications included anti-hypertensives, L-thyroxine 50 μg daily, linagliptin, insulin, aspirin, atorvastatin, and thiamine. On admission, the TSH was 83 mIU/l, free T4 6.5 pmol/l and free T3 was 1.9 pmol/l; four months earlier, the TS...

ea0074ncc4 | Highlighted Cases | SFENCC2021

A rare case of multiple thrombi and left adrenal haemorrhage following COVID-19 vaccination

Boyle Luke D , Morganstein Daniel L , Mitra Indu , Nogueira Edson F

Case history: A 55 year-old female presented to A&E with left iliac fossa pain and vomiting, 8 days following her first dose of the AstraZeneca COVID-19 vaccine. She had a background of hypothyroidism, hypertension and hysterectomy for menorrhagia at age 25 – no prior thrombotic history. She underwent emergency laparoscopy for suspected torsion, which was converted to laparotomy for ovarian necrosis secondary to left ovarian vein thrombosis. Post-operatively, isolated...